Skip to content
Hi-Doctor
← Back to consultationInternal patient-safety page

MEDICATION SAFETY

Dutasteride safety summary

  • INN
  • dutasteride
  • dual 5α-reductase inhibitor (types I + II)
  • 0.5 mg oral capsule

Dutasteride blocks both type-I and type-II 5α-reductase, lowering DHT more completely than finasteride. It is used for androgenetic alopecia in men when a stronger anti-androgen response is appropriate, and for benign prostatic hyperplasia.

Adult men with androgenetic alopecia, often after an inadequate finasteride response, or for benign prostatic hyperplasia.

  • 0.5 mg orally once a day, with or without food.
  • Half-life is long (3–5 weeks): plasma levels persist after stopping, side effects can take time to resolve.
  • Stopping treatment reverses hair-loss gains over 6–12 months.

  • Depressive symptoms or suicidal thoughts — stop and seek care.
  • Breast lumps, pain or nipple discharge.
  • Severe allergic reaction (angio-oedema).
  • Persistent sexual side effects after stopping treatment.

WHEN TO CALL THE DOCTOR

Call us through the in-app chat if you notice…

  • Persistent low mood or thoughts of self-harm — stop the medicine and contact us same day.
  • Sexual side effects that don't settle within a few months.
  • Any breast change (lumps, pain, discharge).
  • Pregnancy in your partner — capsules should not be handled by pregnant women.

OFFICIAL SOURCE

This summary is condensed from the regulator's full product leaflet for ease of reading. The complete document — every interaction, dose adjustment and reporting note — is one click away.

AEMPS CIMA — Dutasteride 0.5 mg

This page summarises information from the regulator-approved leaflet for reference only. It is not medical advice and does not replace the assessment of an EU-licensed doctor. Your doctor will review your individual history, dose and interactions during your consultation.

← Back to consultationYou can print this page for your records.

HI-DOCTOR NEWSLETTER

We'll tell you when we add new treatments.

At most 2 emails a month. No spam. Updates on online health, EU telemedicine, and clinical guides signed by licensed doctors.